Intestinal Microbiota Transplant (IMT), sometimes called Faecal Microbiota Transplant (FMT) treatment that transfers healthy gut bacteria from a screened donor to a patient, helping to restore balance in the gut microbiome and treat certain conditions.
What on earth is IMT?
Imagine if your gut had a reset button—a way to restore balance when things go haywire. That's essentially what IMT offers. By transferring stool from a healthy donor into the gut of someone struggling with certain intestinal issues, IMT aims to reintroduce beneficial microbes and set things right.
How is IMT created?
The process of making IMT is more high-tech than you might think and involves a lot of consideration and testing to ensure it is safe.• Donor selection – Not just anyone can be a stool donor. Potential donors undergo rigorous screening—including health questionnaires and blood and stool tests—to ensure they are free from infections and other health concerns.• Sample processing – Once a donor is cleared, their stool sample is processed in a lab. This involves filtering out unwanted material and isolating the beneficial microbiome. The sample is then prepared according to how it is administered (given) to the patient (see below).
How is IMT administered?
IMT can be given from the upper part or the lower part of the gastrointestinal route.
Upper gastrointestinal route:
- Nasogastric tube – A thin tube is inserted through the nose into the stomach.
- Nasoduodenal or Nasojejunal Tube – The tube is placed deeper into the small intestine.
- Capsules
Lower gastrointestinal route
- Colonoscopy – A flexible tube delivers the IMT directly into the colon.
- Enema – The sample is introduced through the rectum.
Each method has its own advantages, and the choice depends on factors like the patient’s condition and doctor’s recommendation.
Each method has its own advantages, and the choice depends on factors like the patient’s condition and doctor’s recommendation.
When is IMT the go-to solution?
IMT has gained prominence primarily for treating a recurrent version of a bacterial gut infection called C. difficile — a condition causing severe diarrhoea and colitis (inflammation of the colon). It is now standard care for patients with this infection and is approved in national and NICE guidelines for this purpose. When standard antibiotic treatments fail, IMT has shown remarkable success in restoring gut health for these patients.
While IMT's efficacy in treating C. difficile infections is well-established, researchers are exploring its potential for other conditions:
- Inflammatory Bowel Diseases (IBD): Preliminary studies are investigating IMT's role in managing conditions like ulcerative colitis and Crohn's disease.
- Metabolic disorders: There's ongoing research into how IMT might influence conditions such as obesity and diabetes by altering the gut microbiome.
- Liver diseases: There is growing interest in using IMT for liver diseases, where gut microbiome imbalances may contribute to conditions like cirrhosis and primary sclerosing cholangitis.
- Restoring gut health: Researchers are exploring whether IMT could help restore gut health after treatments that severely impact the gut microbiome such as chemotherapy, cancer immunotherapy or intensive and extended use of antibiotics.
However, these applications are still under investigation, and more research is needed to determine IMT's effectiveness beyond C. difficile infections. As research continues, IMT may become a valuable tool for a wider range of conditions, offering new possibilities for gut-related and systemic health issues.
Don't try this at home!
Beyond the donor risks, the method of delivering the sample without medical supervision can also lead to serious complications. Without proper screening, hygiene, and administration, a self-administered IMT could do more harm than good. If you’re considering this treatment, always seek advice from a qualified medical professional—your gut (and your health) will thank you!
The future of IMT
IMT represents a fascinating intersection of ancient practices and modern science. By harnessing the power of a healthy gut microbiome, IMT offers hope for patients battling persistent intestinal infections. As research advances, who knows what other gut-related ailments might be tackled with this innovative approach?
Links/resources
IMT patient information leaflet (Guts UK! website)
British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) IMT/ FMT guidelines(BMJ Gut Journals)